BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27180129)

  • 1. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
    Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
    Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
    Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
    J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.
    Petit C; Dumas I; Chargari C; Martinetti F; Maroun P; Doyeux K; Tailleur A; Haie-Meder C; Mazeron R
    Brachytherapy; 2016; 15(4):463-470. PubMed ID: 27180130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
    Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
    Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
    Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
    Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
    J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.